Levi & Korsinsky Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - DOCS
Levi & Korsinsky, LLP is reminding Doximity, Inc. investors of a pending class action lawsuit with a lead plaintiff deadline of November 16, 2026. The lawsuit alleges that Doximity (NYSE: DOCS) made misleading statements to investors regarding its Newsfeed's impact on revenue, competitive position, and advertising methods between August 8, 2024, and May 13, 2026. The firm highlights discrepancies between the company's public promises of strength and reported results, which included lowered revenue guidance and decelerating sales growth leading to significant stock price declines.
Levi & Korsinsky Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - DOCS
Levi & Korsinsky, LLP has highlighted a class action lawsuit against Doximity, Inc. (NYSE:DOCS) for investors who purchased securities between August 8, 2024, and May 13, 2026. The lawsuit alleges that Doximity overstated its Newsfeed's impact on revenue growth and misstated its competitive position, leading to significant stock declines. Investors have until November 16, 2026, to apply for lead plaintiff status.
Robbins LLP Urges DOCS Stockholders Who Lost Money Investing in Doximity, Inc. to Contact the Firm for Information About Leading the Class Action Lawsuit
Robbins LLP is urging Doximity, Inc. (NYSE: DOCS) stockholders who suffered losses to contact the firm regarding a class action lawsuit. The lawsuit alleges that Doximity failed to disclose it was losing market share to competitors with more favorable pricing and engagement models, and overstated the impact of its "Newsfeed" on revenue growth. Investors who purchased DOCS stock between August 8, 2024, and May 13, 2026, have until November 16, 2026, to seek appointment as lead plaintiff.
Kaplan Fox Encourages Doximity, Inc. (NYSE: DOCS) Investors to Contact the Firm Before the Deadline on November 16, 2026
Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Doximity, Inc. (NYSE: DOCS) on behalf of investors who purchased stock between August 8, 2024, and May 13, 2026. The lawsuit alleges Doximity overstated the impact of its Newsfeed on revenue growth and lost market share, leading to a significant stock price drop on May 14, 2026. Investors are encouraged to contact Kaplan Fox before the lead plaintiff deadline of November 16, 2026.
Recover Investment Losses: Class Action Initiated Against Doximity, Inc. (DOCS)
Levi & Korsinsky, LLP has initiated a securities class action lawsuit against Doximity, Inc. (NYSE:DOCS) on behalf of investors who suffered losses due to alleged securities fraud between August 8, 2024, and May 13, 2026. The lawsuit claims Doximity made false statements regarding its Newsfeed's revenue impact, market share, and advertising methods, including the undisclosed use of banner ads and email newsletters. Investors affected by these alleged misrepresentations are encouraged to learn about their rights to seek recovery.
Doximity, Inc. (DOCS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP has announced that Doximity, Inc. (DOCS) shareholders who suffered losses between August 8, 2024, and May 13, 2026, have an opportunity to lead a securities fraud class action lawsuit. The lawsuit alleges that Doximity made misleading statements regarding its revenue growth, market share, and engagement tactics. Investors have until November 16, 2026, to file to be considered as lead plaintiff in the case.
DOCS Deadline Alert: SueWallSt Reminds Doximity, Inc. (DOCS) Investors of Securities Class Action Deadline on November 16, 2026
SueWallSt is alerting Doximity, Inc. (DOCS) investors about a securities class action lawsuit with a lead plaintiff deadline of November 16, 2026. The lawsuit alleges that Doximity overstated the revenue contribution of its "Newsfeed" product and misrepresented its competitive standing, leading to significant stock declines. Institutional investors who purchased securities between August 8, 2024, and May 13, 2026, are encouraged to assess their potential losses and consider their options for recovery.
INVESTOR ALERT: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - DOCS
Robbins Geller Rudman & Dowd LLP announced an investor alert for Doximity, Inc. (NYSE: DOCS) shareholders who experienced substantial losses. Investors who purchased Doximity common stock between August 8, 2024, and May 13, 2026, have until November 16, 2026, to seek lead plaintiff status in a class action lawsuit. The lawsuit alleges that Doximity made false or misleading statements regarding its revenue growth from Newsfeed and its market share against competitors.
ROSEN, TOP-RANKED TRIAL ATTORNEYS, Encourages Doximity,
The Rosen Law Firm is encouraging investors of Doximity, Inc. (NYSE: DOCS) who purchased common stock between August 8, 2024, and May 13, 2026, to secure legal counsel before the November 16, 2026, lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that Doximity overstated the impact of its Newsfeed on revenue growth and was losing market share due to less favorable pricing and engagement models. Investors can join the class action to potentially recover damages.
Class Action Lawsuit Filed: Doximity, Inc. (DOCS) - Join by November 16, 2026 - Contact Levi & Korsinsky
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Doximity, Inc. (NYSE:DOCS) on behalf of investors who suffered losses due to alleged securities fraud between August 8, 2024, and May 13, 2026. The lawsuit claims Doximity made false and misleading statements about its Newsfeed being its primary revenue driver and its advertising methods, while allegedly losing market share and relying on banner ads and email newsletters. Investors who purchased DOCS securities during the specified period are encouraged to contact Levi & Korsinsky to explore potential recovery.
DOCS UPCOMING DEADLINE: Levi & Korsinsky Alerts Doximity, Inc. Stockholders of Securities Class Action - Contact the Firm
Levi & Korsinsky, LLP has alerted Doximity, Inc. (NYSE: DOCS) stockholders about a pending securities class action. The lawsuit alleges that Doximity made misleading statements about its Newsfeed's revenue impact and competitive position, leading to three significant stock declines between November 2025 and May 2026. Shareholders who purchased stock between August 8, 2024, and May 13, 2026, have until November 16, 2026, to seek lead plaintiff status.
DOCS UPCOMING DEADLINE: Levi & Korsinsky Alerts Doximity, Inc. Stockholders of Securities Class Action - Contact the Firm
Levi & Korsinsky, LLP has alerted stockholders of Doximity, Inc. (NYSE: DOCS) about an upcoming deadline for a securities class action lawsuit. The lawsuit alleges that Doximity made misleading statements regarding its Newsfeed's revenue impact and competitive position, leading to three significant stock declines between November 2025 and May 2026. Investors who purchased securities between August 8, 2024, and May 13, 2026, have until November 16, 2026, to seek lead plaintiff status.
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard
Bernstein Liebhard LLP has issued a shareholder alert for Doximity, Inc. (DOCS) investors, reminding them of an upcoming November 16, 2026 deadline for a securities fraud class action lawsuit. The lawsuit alleges that Doximity made false and misleading statements about its business, leading to inflated stock prices and investor losses for those who purchased shares between August 8, 2024, and May 13, 2026. Investors who suffered losses are encouraged to contact the firm.
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Doximity, Inc. (DOCS) Investors of November 16, 2026 Deadline
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Doximity, Inc. (NYSE:DOCS) on behalf of investors who purchased securities between August 8, 2024, and May 13, 2026. The lawsuit alleges that Doximity made false and misleading statements regarding its Newsfeed's revenue impact and its advertising methods. Investors who suffered losses are encouraged to contact the firm to explore potential recovery before the November 16, 2026 deadline.
Kaplan Fox Encourages Doximity, Inc. (NYSE: DOCS) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 16, 2026
Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Doximity, Inc. (NYSE: DOCS) on behalf of investors who purchased stock between August 8, 2024, and May 13, 2026. The lawsuit alleges that Doximity overstated the revenue impact of its Newsfeed and lost market share, leading to a significant stock price drop after missing revenue guidance on May 13, 2026. Investors are encouraged to contact Kaplan Fox before the lead plaintiff deadline of November 16, 2026.
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS
Rosen Law Firm is encouraging investors of Doximity, Inc. (NYSE: DOCS) to secure legal counsel before the November 16, 2026, lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Doximity overstated the impact of its Newsfeed on revenue growth and was losing market share due to competitors' more favorable pricing. Investors who purchased Doximity common stock between August 8, 2024, and May 13, 2026, may be entitled to compensation.
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS
Rosen Law Firm is encouraging investors of Doximity, Inc. (NYSE: DOCS) to secure legal counsel before the November 16, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Doximity overstated the impact of its Newsfeed on revenue growth and was losing market share, causing investors damages. The firm, known for its success in securities class actions, is offering representation on a contingency fee basis.
INVESTOR DEADLINE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit before November 16, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - DOCS
Robbins Geller Rudman & Dowd LLP announces a class action lawsuit against Doximity, Inc. (NYSE: DOCS) for alleged violations of the Securities Exchange Act of 1934. Investors who purchased Doximity common stock between August 8, 2024, and May 13, 2026, have until November 16, 2026, to seek appointment as lead plaintiff. The lawsuit claims Doximity made false and misleading statements regarding its revenue growth from Newsfeed and its market share, leading to significant stock price drops following earnings and guidance updates.
ROSEN, A LONGSTANDING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS
Rosen Law Firm is reminding purchasers of Doximity, Inc. common stock between August 8, 2024, and May 13, 2026, about the upcoming November 16, 2026 lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that Doximity overstated the impact of its Newsfeed on revenue growth and was losing market share, causing investors damages. The firm encourages affected investors to seek counsel and join the class action.
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Doximity, Inc. (NYSE: DOCS) on behalf of investors who purchased securities between August 8, 2024, and May 13, 2026. The lawsuit alleges that Doximity made false and misleading statements regarding its Newsfeed's impact on revenue growth, market share, and advertising practices. Investors who suffered losses are encouraged to join the case, with a lead plaintiff deadline of November 16, 2026.
DOCS DEADLINE: Levi & Korsinsky Reminds Doximity, Inc. Investors of Upcoming Securities Class Action Deadline
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS) on behalf of investors who purchased common stock between August 8, 2024, and May 13, 2026. The lawsuit alleges that the company overstated the revenue impact of its "Newsfeed" product while losing market share. The CEO and former CFO are named as alleged controlling persons, and the deadline for investors to apply for lead plaintiff is November 16, 2026.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
The Rosen Law Firm is reminding purchasers of Doximity, Inc. (NYSE: DOCS) common stock between August 8, 2024, and May 13, 2026, about the lead plaintiff deadline of November 16, 2026, in a securities class action lawsuit. The lawsuit alleges that Doximity overstated the impact of its Newsfeed on revenue growth and was losing market share due to competitors' more favorable pricing and engagement models, leading to investor damages. Investors who purchased during this period are encouraged to secure counsel.
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
The Rosen Law Firm is reminding purchasers of Doximity, Inc. (NYSE: DOCS) common stock between August 8, 2024, and May 13, 2026, about an upcoming lead plaintiff deadline on November 16, 2026, for a securities fraud lawsuit. The lawsuit alleges that Doximity overstated the impact of its Newsfeed on revenue growth and was losing market share due to less favorable pricing and engagement models. Investors who purchased during this period may be entitled to compensation and are encouraged to join the class action.
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS
Rosen Law Firm is reminding purchasers of Doximity, Inc. common stock between August 8, 2024, and May 13, 2026, about an important November 16, 2026, deadline to seek lead plaintiff status in a securities class action lawsuit. The lawsuit alleges that Doximity overstated the impact of its Newsfeed on revenue growth and was losing market share due to less favorable pricing and engagement models. Investors who purchased during this period may be entitled to compensation.
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP (SBS) has announced a class action lawsuit against Doximity, Inc. (NYSE: DOCS) for alleged securities fraud, inviting investors who purchased shares between August 8, 2024, and May 13, 2026, to participate. The lawsuit claims Doximity made false and misleading statements regarding its Newsfeed product's impact on revenue and its reliance on banner ads, leading to investor damages. The deadline to seek lead plaintiff appointment is November 16, 2026.
Securities Class Action Lawsuit Filed Against Doximity, Inc. (DOCS) - Levi & Korsinsky Represents Shareholders
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Doximity, Inc. (NYSE:DOCS) on behalf of investors who purchased securities between August 8, 2024, and May 13, 2026. The lawsuit alleges that Doximity made false and misleading statements regarding its Newsfeed's impact on revenue growth, its market share, and its advertising methods, including an over-reliance on banner ads and email newsletters despite claims to the contrary. Shareholders who suffered losses are encouraged to contact Levi & Korsinsky to explore potential recovery under federal securities laws.
DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
SueWallSt has issued a shareholder alert regarding a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS). The lawsuit alleges that Doximity overstated its Newsfeed's contribution to revenue growth and misrepresented its competitive position, leading to significant stock price declines for investors who purchased shares between August 8, 2024, and May 13, 2026. Investors with losses are encouraged to contact SueWallSt by the lead plaintiff deadline of November 16, 2026, to learn about recovering their losses.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS
Pomerantz LLP has filed a class action lawsuit against Doximity, Inc. (NYSE: DOCS) on behalf of investors who suffered losses. The lawsuit alleges securities fraud or other unlawful business practices by Doximity and its officers/directors. Investors have until November 16, 2026, to apply to be Lead Plaintiff, following significant stock price drops after disappointing financial guidance and results.
DOCS Class Action Reminder - Robbins LLP Reminds Investors
Robbins LLP is reminding investors that a class action lawsuit has been filed against Doximity, Inc. (NYSE: DOCS) for allegedly misleading investors about its market share and revenue growth, particularly concerning its Newsfeed product. The complaint claims Doximity failed to disclose it was losing market share to competitors and relied on advertising methods it publicly disavowed. Investors who suffered losses between August 8, 2024, and May 13, 2026, have until November 16, 2026, to contact Robbins LLP to participate as lead plaintiff.
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
The Rosen Law Firm has announced a class action lawsuit against Doximity, Inc. (NYSE: DOCS) on behalf of investors who purchased common stock between August 8, 2024, and May 13, 2026. The lawsuit alleges that Doximity overstated the impact of its Newsfeed on revenue growth and was losing market share due to less favorable engagement models. Investors who wish to serve as lead plaintiff must move the Court by November 16, 2026.
Law Offices of Frank R. Cruz Encourages Doximity, Inc. (DOCS) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz has filed a class action lawsuit against Doximity, Inc. (DOCS) on behalf of shareholders who purchased stock between August 8, 2024, and May 13, 2026. The lawsuit alleges that Doximity made materially false and/or misleading statements regarding its business, operations, and prospects, leading to significant stock price declines after the company announced lower-than-expected financial results on multiple occasions. Shareholders who suffered losses are encouraged to inquire about the securities fraud class action by November 16, 2026, to potentially recover their losses.
Doximity, Inc. (DOCS) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 16, 2026 Deadline
Levi & Korsinsky, LLP has announced a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS) on behalf of investors who purchased securities between August 8, 2024, and May 13, 2026. The lawsuit alleges that Doximity made false and misleading statements regarding its Newsfeed's revenue impact and its advertising methods. Investors who suffered losses are encouraged to contact Levi & Korsinsky, LLP by the November 16, 2026 deadline.
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP has issued a shareholder alert for Doximity, Inc. (NYSE: DOCS) investors, reminding them of the November 16, 2026, deadline to join a securities fraud class action lawsuit. The lawsuit alleges that Doximity made false and misleading statements about its business operations and financial stability between August 8, 2024, and May 13, 2026, leading to artificially inflated stock prices and investor losses. Investors who purchased shares during this period and suffered losses are encouraged to contact the firm.
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP has issued a shareholder alert for Doximity, Inc. (NYSE: DOCS) investors, reminding them of the November 16, 2026 deadline to join a securities fraud class action lawsuit. The lawsuit alleges that Doximity made false and misleading statements about its business and financial stability, leading to inflated stock prices and investor losses. Investors who purchased shares between August 8, 2024, and May 13, 2026, are encouraged to contact the firm.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS
Pomerantz LLP has filed a class action lawsuit against Doximity, Inc. (NYSE: DOCS) on behalf of investors who suffered losses. The lawsuit alleges securities fraud or unlawful business practices, citing significant drops in Doximity's stock price following cautious outlooks, lowered revenue guidance, and missed projections. Investors have until November 16, 2026, to apply to be Lead Plaintiff.
DOCS INVESTOR DEADLINE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - November 16, 2026 Deadline
Robbins Geller Rudman & Dowd LLP announced a class action lawsuit deadline for Doximity, Inc. (NYSE: DOCS) investors who purchased common stock between August 8, 2024, and May 13, 2026. The lawsuit alleges Doximity made false or misleading statements regarding its revenue growth from Newsfeed, market share, and engagement tactics, leading to significant stock price drops. Investors with substantial losses have until November 16, 2026, to seek appointment as lead plaintiff.
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Doximity, Inc. (NYSE: DOCS) and certain officers, alleging federal securities law violations. The lawsuit claims Doximity made false and misleading statements regarding its Newsfeed's impact on revenue, market share, and advertising practices between August 8, 2024, and May 13, 2026. Investors who suffered losses are encouraged to join the case, with a lead plaintiff deadline of November 16, 2026.
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Doximity, Inc. (NYSE: DOCS) and certain officers, alleging violations of federal securities laws. The lawsuit claims Doximity made false or misleading statements regarding its Newsfeed impact on revenue, market share, and advertising practices between August 8, 2024, and May 13, 2026. Investors who purchased Doximity securities during this period are encouraged to join the case, with a lead plaintiff deadline of November 16, 2026.
DOCS Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Doximity, Inc. Securities Class Action - Contact Levi & Korsinsky
Levi & Korsinsky, LLP reminds Doximity, Inc. (NYSE: DOCS) investors of a pending securities class action, with a lead plaintiff deadline of November 16, 2026. The lawsuit alleges that Doximity made misrepresentations about its revenue growth and market share, failing to disclose decelerating sales and contracting net income. Investors who purchased shares between August 8, 2024, and May 13, 2026, and suffered losses may qualify for recovery.
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
This article appears to be a security check page. It does not contain any substantive content about Doximity, Inc. or a class action lawsuit. Therefore, a summary cannot be provided based on the current content.
Doximity CAO Siddharth Sitaram sells $54,043 in class a shares By Investing.com
Doximity's Chief Accounting Officer, Siddharth Sitaram, sold 2,077 Class A shares for $54,043 to cover tax obligations from a stock option exercise. Following this, he holds 96,045 Class A shares. The company's stock is currently trading at $25.94, with a market capitalization of $4.62 billion, and InvestingPro analysis suggests it may be undervalued despite mixed analyst sentiments.
Doximity Director Phoebe L. Yang Watkin Awarded 8,084 RSUs on August 27, 2026
Doximity, Inc. director Phoebe L. Yang Watkin was granted 8,084 restricted stock units (RSUs) on August 27, 2026, as reported in a beneficial ownership filing on August 31, 2026. These RSUs, part of Doximity's non-employee director compensation policy, will vest on the earlier of the first anniversary of the grant or the company’s next annual stockholders meeting, provided she remains a director. Post-grant, Yang Watkin beneficially owns 26,034 shares of Class A Common Stock.
Doximity Director Kevin Spain Granted 8,084 RSUs as Reported in SEC Filing
Doximity Director Kevin Spain was granted 8,084 restricted stock units (RSUs) on August 27, 2026, as disclosed in an SEC Form 4 filing. These RSUs, part of Doximity's non-employee director compensation plan, vest on the earlier of the first anniversary of the grant date or the company's next annual stockholders meeting. Following this grant, Spain directly holds 11,305 shares and has significant indirect ownership through a family trust and Emergence Capital, while disclaiming beneficial ownership for shares held by these entities except for his pecuniary interest.
Fundsmith LLP Has $13.55 Million Stake in Doximity, Inc. $DOCS
Fundsmith LLP reduced its stake in Doximity, Inc. (NYSE:DOCS) by 5.6% in the second quarter, now holding 653,324 shares valued at $13.55 million. Despite mixed analyst ratings, Doximity exceeded Q2 earnings expectations with $0.29 EPS and $156.62 million in revenue, a 7.3% year-over-year increase. Institutional investors own 87.19% of the company, while insiders sold shares worth $437,251 in the last quarter.
The Technical Signals Behind (DOCS) That Institutions Follow
This article provides a technical analysis of Doximity Inc. Class A (NASDAQ: DOCS), highlighting a potential shift in near-term sentiment and an ongoing breakout. It details three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, including support and resistance levels. The report suggests compelling upside potential as no resistance levels remain above the current price if the breakout is sustained.
Doximity (NYSE:DOCS) Director Sells 2,000 Shares
Doximity Director Kira Scherer Wampler sold 2,000 shares of DOCS stock for $49,900, reducing her ownership by 9.16%. The company recently exceeded quarterly earnings expectations with $0.29 EPS and $156.62 million in revenue, up 7.3% year-over-year. Analysts currently hold a consensus "Hold" rating with a price target of $32.43 for Doximity.
Doximity CAO Siddharth Sitaram sells $44,143 of class A stock
Doximity's Chief Accounting Officer, Siddharth Sitaram, sold 1,770 shares of Class A Common Stock for $44,143 on August 13, 2026, as part of a pre-arranged trading plan to cover tax withholding obligations. This transaction followed his exercise of stock options for 5,000 Class B shares, which converted to Class A. Despite a 45% year-to-date decline in share price, InvestingPro analysis suggests the stock is undervalued, while the company maintains a strong balance sheet and gross profit margin.
Doximity Chief Accounting Officer Sitaram Siddharth disposes of Class A shares worth $141,551.80
Doximity's Chief Accounting Officer, Sitaram Siddharth, has reduced his stake in Class A common stock, disposing of shares worth $141,551.80. Following a 5,000-share acquisition and subsequent sales and tax withholdings, his total holdings now stand at 93,122 shares. The transactions occurred in mid-August 2026.
Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.
Doximity's CFO, Matthew Sonefeldt, recently filed a Form 4 showing a non-discretionary disposition of 15,311 shares worth approximately $380,000, solely to cover tax withholding obligations from vested restricted stock units. This transaction is not indicative of his outlook on the company, as he retains significant equity. The article also highlights Doximity's business fundamentals, recent financial performance, and Sonefeldt's focus on long-term growth strategies, drawing parallels to LinkedIn's ad business development.
Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?
Doximity CEO Jeffrey Tangney sold 8,505 shares of Class A Common Stock worth approximately $211,000. This sale was a non-discretionary event to cover tax obligations from vested restricted stock units, representing only a 0.3% reduction in his direct holdings. Tangney still retains a significant 1% ownership interest in the company, amounting to over 2.5 million shares.
